Literature DB >> 6751530

Doxorubicin cardiotoxicity.

D V Unverferth, R D Magorien, C V Leier, S P Balcerzak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6751530     DOI： 10.1016/s0305-7372(82)80014-5

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  17 in total

Review 1.  Cardiotoxicity of doxorubicin and other anthracycline derivatives.

Authors:  D Jain
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

2.  Evidence for the lack of involvement of free radicals in adriamycin-induced histamine release from rat peritoneal cells.

Authors:  L Candussio; F Bartoli Klugmann; G Decorti; L Baldini
Journal:  Agents Actions       Date:  1988-04

Review 3.  Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.

Authors:  M J Moore; C Erlichman
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

4.  Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function compound, HO-3867.

Authors:  Alex Dayton; Karuppaiyah Selvendiran; Sarath Meduru; Mahmood Khan; M Lakshmi Kuppusamy; Shan Naidu; Tamás Kálai; Kálmán Hideg; Periannan Kuppusamy
Journal:  J Pharmacol Exp Ther       Date:  2011-07-28       Impact factor: 4.030

5.  Doxorubicin-heparin complex: reduction of cardiotoxicity of doxorubicin.

Authors:  Y Mizuno; T Hara; S Tachibana; K Uragoh; K Akazawa; K Ueda
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

6.  Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin.

Authors:  P Pouna; S Bonoron-Adèle; G Gouverneur; L Tariosse; P Besse; J Robert
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 7.  Acute myeloid leukemia in the elderly: biological features and search for adequate treatment.

Authors:  V Heinemann; U Jehn
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

8.  Nonimmunological release of histamine from rat mast cells elicited by antineoplastic agents: effect of drug combinations.

Authors:  L M Botana; E Arnaez; M R Vieytes; A Alfonso; M C Louzao
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Effect of amrinone on anthracycline-induced lethal and cardiac toxicity in mice and rats.

Authors:  F Villani; C Manzotti; M Mella; E Monti; G Savi; F Zunino
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

Review 10.  Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy.

Authors:  L R Wiseman; C M Spencer
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.